Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
Here is Why Growth Investors Should Buy Catalyst (CPRX) Now
02:27pm, Monday, 03'rd Apr 2023
Catalyst (CPRX) possesses solid growth attributes, which could help it handily outperform the market.
Here is What to Know Beyond Why Catalyst Pharmaceuticals, Inc. (CPRX) is a Trending Stock
10:39am, Monday, 03'rd Apr 2023
Catalyst (CPRX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks
12:33pm, Friday, 24'th Mar 2023
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Wall Street Analysts Think Catalyst (CPRX) Could Surge 26.44%: Read This Before Placing a Bet
11:29am, Wednesday, 22'nd Mar 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 26.4% in Catalyst (CPRX). While the effectiveness of this highly sought-after metric is questionable, the posit
Is Trending Stock Catalyst Pharmaceuticals, Inc. (CPRX) a Buy Now?
10:43am, Tuesday, 21'st Mar 2023
Recently, Zacks.com users have been paying close attention to Catalyst (CPRX). This makes it worthwhile to examine what the stock has in store.
3 Stocks With Solid Earnings Growth to Buy Right Away
08:28am, Tuesday, 21'st Mar 2023
Invest in stocks like Catalyst Pharmaceuticals (CPRX), Terex (TEX) & Arista Networks (ANET) at the moment for superb earnings growth.
Is It Worth Investing in Catalyst (CPRX) Based on Wall Street's Bullish Views?
10:44am, Friday, 17'th Mar 2023
The average brokerage recommendation (ABR) for Catalyst (CPRX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after
3 Reasons Why Growth Investors Shouldn't Overlook Catalyst (CPRX)
02:29pm, Thursday, 16'th Mar 2023
Catalyst (CPRX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Catalyst's (CPRX) Q4 Earnings & Sales Top, Boosted by Firdapse
01:46pm, Thursday, 16'th Mar 2023
Catalyst Pharmaceuticals (CPRX) reports better-than-expected financial performance as it beats both earnings and revenue estimates. Firdapse sales continue to grow year over year.
Catalyst Pharmaceutical (CPRX) Q4 Earnings and Revenues Surpass Estimates
07:05pm, Wednesday, 15'th Mar 2023
Catalyst (CPRX) delivered earnings and revenue surprises of 4.76% and 0.19%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Catalyst Pharma The No. 1 Biotech, Just Crushed 2023 Guidance Estimates
04:22pm, Wednesday, 15'th Mar 2023
Catalyst Pharmaceuticals topped fourth-quarter expectations and delivered strong guidance. In response, CPRX stock rose late Wednesday.
Catalyst Pharmaceuticals, Inc. (CPRX) is Attracting Investor Attention: Here is What You Should Know
10:44am, Friday, 10'th Mar 2023
Recently, Zacks.com users have been paying close attention to Catalyst (CPRX). This makes it worthwhile to examine what the stock has in store.
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on March 15, 2023
08:03am, Wednesday, 01'st Mar 2023
The Company Will Host a Conference Call and Webcast on March 16, 2023, at 8:30 AM ET The Company Will Host a Conference Call and Webcast on March 16, 2023, at 8:30 AM ET
3 Top Profitable Stocks to Buy on Solid Net Income Ratio
09:02am, Tuesday, 28'th Feb 2023
Lamb Weston (LW), Catalyst Pharmaceuticals (CPRX) and Northeast Community Bancorp (NECB) are some of the top picks with a high net income ratio.
Will Catalyst (CPRX) Beat Estimates Again in Its Next Earnings Report?
01:33pm, Monday, 27'th Feb 2023
Catalyst (CPRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
